✦ LIBER ✦

Effects of concomitant drugs on sitagliptin-mediated improvement in glycemic control in Japanese patients with type 2 diabetes

✍ Scribed by Hirata, Takumi; Inukai, Kouichi; Morimoto, Jiro; Katayama, Shigehiro; Ishida, Hitoshi

Book ID: 122119423
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 509 KB
Volume: 8
Category: Article
ISSN: 1751-9918
DOI: 10.1016/j.pcd.2014.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vildagliptin dose-dependently improves g

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

✍ Masatoshi Kikuchi; Nobuyuki Abe; Mitsutoshi Kato; Shinji Terao; Nobuyuki Mimori; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Sitagliptin added to treatment with ongo

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

✍ Atsunori Kashiwagi; Takashi Kadowaki; Naoko Tajima; Kenji Nonaka; Tadaaki Tanigu 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 242 KB

Effect of Sitagliptin as Add-on Therapy

Effect of Sitagliptin as Add-on Therapy in Elderly Type 2 Diabetes Patients With Inadequate Glycemic Control in Taiwan

✍ Ming-Nan Chien; Chun-Chuan Lee; Wei-Che Chen; Sung-Chen Liu; Ching-Hsiang Leung; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Effects of Sitagliptin on 24-H Glycemic

Effects of Sitagliptin on 24-H Glycemic Changes in Japanese Patients with Type 2 Diabetes Assessed Using Continuous Glucose Monitoring

✍ Mori, Yutaka; Taniguchi, Yukiko; Matsuura, Kenichi; Sezaki, Kazunori; Yokoyama, 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 272 KB

Ipragliflozin improves glycemic control

Ipragliflozin improves glycemic control in Japanese patients with type 2 diabetes mellitus: the BRIGHTEN study

✍ Kashiwagi, Atsunori; Kazuta, Kenichi; Takinami, Yuusuke; Yoshida, Satoshi; Utsun 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 458 KB

Effect of the Dipeptidyl Peptidase-4 Inh

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

✍ Aschner, P.; Kipnes, M. S.; Lunceford, J. K.; Sanchez, M.; Mickel, C.; Williams- 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 182 KB